170 related articles for article (PubMed ID: 36650915)
41. [Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia].
Jover E; Aranda JL; Nogués X; del Palacio A; Rubiés-Prat J
Med Clin (Barc); 1996 May; 106(20):776-9. PubMed ID: 8801396
[TBL] [Abstract][Full Text] [Related]
42. The effect of dextran on plasma lipids. A study on patient with essential hypercholesterolemia or hyperlipemia.
Blohmé G; Kerstell J; Svanborg A
Acta Med Scand; 1968 May; 183(5):481-5. PubMed ID: 5703642
[No Abstract] [Full Text] [Related]
43. Effect of high molecular weight dextran on experimental hypercholesterolemia.
Brahmankar DM; Connor WE
Circ Res; 1967 Dec; 21(6):817-21. PubMed ID: 6078143
[No Abstract] [Full Text] [Related]
44. [Drug therapy of hypercholesterolemia].
Schwandt P; Richter WO
Wien Klin Wochenschr; 1995; 107(18):544-8. PubMed ID: 7483641
[TBL] [Abstract][Full Text] [Related]
45. Long term human studies on the lipid effects of oral calcium.
Bierenbaum ML; Fleischman AI; Raichelson RI
Lipids; 1972 Mar; 7(3):202-6. PubMed ID: 5021330
[No Abstract] [Full Text] [Related]
46. Fish oil supplementation does not lower plasma cholesterol in men with hypercholesterolemia. Results of a randomized, placebo-controlled crossover study.
Wilt TJ; Lofgren RP; Nichol KL; Schorer AE; Crespin L; Downes D; Eckfeldt J
Ann Intern Med; 1989 Dec; 111(11):900-5. PubMed ID: 2683921
[TBL] [Abstract][Full Text] [Related]
47. Benefits of hypercholesterolemia treatment.
Soma M; Paoletti R
Pharmacol Res; 1997 Mar; 35(3):159. PubMed ID: 9229398
[No Abstract] [Full Text] [Related]
48. Vitamin A in hypercholesterolemia.
Smith DK; Greene JM; Leonard SB; Kuske TT; Feldman DS; Feldman EB
Am J Med Sci; 1992 Jul; 304(1):20-4. PubMed ID: 1642248
[TBL] [Abstract][Full Text] [Related]
49. Efficacy and safety of pravastatin in the long-term treatment of elderly patients with hypercholesterolemia.
Santinga JT; Rosman HS; Rubenfire M; Maciejko JJ; Kobylak L; McGovern ME; Behounek BD
Am J Med; 1994 Jun; 96(6):509-15. PubMed ID: 8017448
[TBL] [Abstract][Full Text] [Related]
50. Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease.
Castañer O; Pintó X; Subirana I; Amor AJ; Ros E; Hernáez Á; Martínez-González MÁ; Corella D; Salas-Salvadó J; Estruch R; Lapetra J; Gómez-Gracia E; Alonso-Gomez AM; Fiol M; Serra-Majem L; Corbella E; Benaiges D; Sorli JV; Ruiz-Canela M; Babió N; Sierra LT; Ortega E; Fitó M
J Am Coll Cardiol; 2020 Dec; 76(23):2712-2724. PubMed ID: 33272365
[TBL] [Abstract][Full Text] [Related]
51. Comparative efficacy of once-daily versus twice-daily pravastatin in primary hypercholesterolemia.
Pan HY; DeVault AR; Brescia D; Willard DA
Clin Ther; 1991; 13(3):368-72. PubMed ID: 1954638
[TBL] [Abstract][Full Text] [Related]
52. Clinical importance of the evaluation of blood non-HDL cholesterol levels in a hypercholesterolemia education class.
Kotani K; Mu H; Kamezaki S; Kato T; Kurozawa Y
Intern Med; 2006; 45(10):697-8. PubMed ID: 16778344
[No Abstract] [Full Text] [Related]
53. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E;
Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231
[TBL] [Abstract][Full Text] [Related]
54. [Diabetes mellitus, hypercholesterolemia, and therapeutic prospects with simvastatin. General considerations and personal contribution].
Pipicelli G; Pentimone F; Frustaci G; Notarangelo R; Beghè F
Minerva Med; 1992 Dec; 83(12):819-25. PubMed ID: 1491762
[TBL] [Abstract][Full Text] [Related]
55. Antihyperlipidemic effects of Pleurotus ostreatus (oyster mushrooms) in HIV-infected individuals taking antiretroviral therapy.
Abrams DI; Couey P; Shade SB; Kelly ME; Kamanu-Elias N; Stamets P
BMC Complement Altern Med; 2011 Aug; 11():60. PubMed ID: 21831304
[TBL] [Abstract][Full Text] [Related]
56. Interaction between a commercially available St. John's wort product (Movina) and atorvastatin in patients with hypercholesterolemia.
Andrén L; Andreasson A; Eggertsen R
Eur J Clin Pharmacol; 2007 Oct; 63(10):913-6. PubMed ID: 17701167
[TBL] [Abstract][Full Text] [Related]
57. Effects of lovastatin (20-80 mg daily) on lipoprotein fractions in patients with severe primary hypercholesterolemia.
März W; Grützmacher P; Paul D; Siekmeier R; Schoeppe W; Gross W
Int J Clin Pharmacol Ther; 1994 Feb; 32(2):92-7. PubMed ID: 8004365
[TBL] [Abstract][Full Text] [Related]
58. [Simvastatin versus gemfibrozil in the treatment of primary hypercholesterolemia in hypertensive patients treated with hydrochlorothiazide].
Berioli S; Bentivoglio M; Conti R; Osanna RA; Savino K; Zollino L; Corea L
Cardiologia; 1990 Apr; 35(4):335-40. PubMed ID: 2245435
[TBL] [Abstract][Full Text] [Related]
59. Effects of pravastatin in dyslipidaemic patients with and without hypertension.
Tsukiyama H; Otsuka K
J Hypertens Suppl; 1993 Dec; 11(5):S346-7. PubMed ID: 8158416
[No Abstract] [Full Text] [Related]
60. Residual dyslipidemia among United States adults treated with lipid modifying therapy (data from National Health and Nutrition Examination Survey 2009-2010).
Wong ND; Chuang J; Wong K; Pham A; Neff D; Marrett E
Am J Cardiol; 2013 Aug; 112(3):373-9. PubMed ID: 23642513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
